Literature DB >> 12185598

Rare mutations of the DMBT1 gene in human astrocytic gliomas.

Wolf Mueller1, Jan Mollenhauer, Florian Stockhammer, Annemarie Poustka, Andreas von Deimling.   

Abstract

The Deleted in Malignant Brain Tumors 1 gene (DMBT1) has been proposed as a tumor suppressor gene candidate in human brain tumors, based on the observation of homozygous deletions affecting the DMBT1 region or part of the gene. In order to support this hypothesis, we performed a mutational analysis of the entire coding region of DMBT1, employing SSCP analysis and direct DNA sequencing in a series of 79 astrocytic gliomas. Five somatic mutations were detected. Two mutations, one of which resulted in an amino acid exchange, occurred in glioblastomas. One pilocytic astrocytoma carried two missense mutations and another pilocytic astrocytoma contained a somatic mutation, not affecting the presumed protein. In addition, 21 of the 27 single nucleotide polymorphisms identified in this study have not been recognized previously. The data indicate, that small mutations are not a frequent finding in gliomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185598     DOI: 10.1038/sj.onc.1205733

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; N Lale Satiroglu-Tufan; Canten Tataroglu; Zehra Kesen; Z Ozlem Doğan; Sunde Yılmaz; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2011-09-29       Impact factor: 2.316

Review 2.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.

Authors:  Sara Franceschi; Francesca Lessi; Paolo Aretini; Valerio Ortenzi; Cristian Scatena; Michele Menicagli; Marco La Ferla; Prospero Civita; Katia Zavaglia; Claudia Scopelliti; Alessandro Apollo; Francesco Giovanni Carbone; Riccardo Vannozzi; Generoso Bevilacqua; Francesco Pasqualetti; Antonio Giuseppe Naccarato; Chiara Maria Mazzanti
Journal:  Oncotarget       Date:  2018-05-08

4.  DMBT1 expression is down-regulated in breast cancer.

Authors:  P Braidotti; P G Nuciforo; J Mollenhauer; A Poustka; C Pellegrini; A Moro; G Bulfamante; G Coggi; S Bosari; G G Pietra
Journal:  BMC Cancer       Date:  2004-08-09       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.